Table 2. Clinical data of 24 patients at the time of diagnosis of BKVN and 12 and 24 months after follow-up.
| Baseline at diagnosis | Follow-up of 12 months | P* | Follow-up of 24 months | P** | |
|---|---|---|---|---|---|
| Decoy cells (/HPF) | 28.0 (13.8–56.8) | 0 (0–0) | <0.001 | 0 (0–0) | <0.001 |
| Urine BKV-DNA (copies/ml) | 2.1 × 109 (7.3 × 108 to 5.9 × 109) | 5.9 × 106 (1.5 × 105 to 3.2 × 107) | <0.001 | 3.7 × 105 (1.0 × 106 to 5.9 × 107) | <0.001 |
| Blood BKV-DNA (copies/ml) | 1.4 × 104 (4.5 × 103 to 9.0 × 104) | 0 (0–0) | <0.001 | 0 (0–0) | <0.001 |
| Serum creatinine (umol/l) | 160.6 ± 47.3 | 166.5 ± 75.7 | 0.748 | 159.8 ± 88.9 | 0.963 |
| eGFR (ml/min) | 46.0 ± 15.5 | 47.4 ± 17.2 | 0.774 | 51 ± 18.3 | 0.252 |
*, P-value of the comparison between the time of 12 months after follow-up and diagnosis of BKVN.
**, P-value of the comparison between the time of 24 months after follow-up and diagnosis of BKVN.